Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Microdosing may offer added cognitive support over time
Oct 9: In a relatively rare move, the FDA went against the recommendation of one of its advisory committees, rejecting a bid by Alnylam to expand Onpattro (patisiran)s label to cardiomyopathy of transthyretin-mediated amyloidosis
Dec 21: The FDA on Thursday signed off on the first and only self-administered treatment for polyneuropathy in hereditary transthyretin-mediated amyloidosis (hATTR-PN): AstraZeneca and Ionis eplontersen, now to be known as Wainua
They will guide you through the Afterpay process during your call to make sure you understand your options and feel comfortable with the amount you pay
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
